Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers

Oncogene

Volumn 18, Issue 13, 1999, Pages 2241-2251

  Pegram, Mark ^a   Hsu, Sheree ^a   Lewis, Gail ^b   Pietras, Richard ^a   Beryt, Malgorzata ^a   Sliwkowski, Mark ^b   Coombs, Daniel ^b   Baly, Deborah ^b   Kabbinavar, Fairooz ^a   Slamon, Dennis ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Breast cancer; Chemotherapy; HER 2 neu (c erbB 2); Multiple drug effects analysis; Synergy

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; PACLITAXEL; THIOTEPA; VINBLASTINE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNOTHERAPY; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALIA;

EID: 0033118889     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202526     Document Type: Article

References (47)

1. Aboud-Pirak E, Hurwitz E, Pirak ME, Bellot F, Schlessinger J and Sela M. (1988). J. Natl. Cancer Inst., 80, 1605-1611.
2. Arteaga CL, Winnier AR, Poirier MC, Lopez-Larraza DM, Shawver LK, Hurd SD and Stewart SJ. (1994). Cancer Res., 54, 3758-3765.
3. Baselga J, Miller W, Norton L and Mendelsohn J. (1992). Proc. Am. Assoc. Cancer Res., 33, 2947.
4. Baselga J, Norton L, Masui H, Pandiella A, Coplan K, Miller Jr WH and Mendelsohn J. (1993). J. Natl. Cancer Inst., 85, 1327-1333.
5. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J Rosen PP, Twaddell T, Henderson IC and Norton L. (1996). J. Clin. Oncol., 14, 737-744.
6. Baselga J, Norton L, Albanell J, Kim YM and Mendelsohn J. (1998). Cancer Res., 58, 2825-2831.
7. Berchuck A, Rodriguez G, Kinney RB, Soper JT, Dodge RK, Clarke-Pearson DL and Bast Jr RC. (1991). Am. J. Obstet. Gynecol., 164, 15-21.
8. Bible KC and Kaufmann SH. (1997). Cancer Res., 57, 3375-3380.
9. Boven E and Winograd B, eds. (1991). The Nude Mouse Oncol. Res. CRC Press, Boca Raton, FL.
10. Buick RN. (1994). Cancer Chemotherapy Handbook, Dorr RT and Von Hoff DD, (eds.) Appleton & Lange: Norwalk, CN. pp. 3-14.
11. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME and Shepard HM (1992). Proc. Natl. Acad. Sci. USA, 89, 4285-4289.
12. Chazin VR, Kaleko M, Miller AD and Slamon DJ. (1992). Oncogene, 9, 1859-1866.
13. Chou T and Talalay P. (1984). Ad. Enzyme Reg., 22, 27-55.
14. De Santes K, Slamon D, Anderson SK, Shepard M, Fendly B, Maneval D and Press O. (1992). Cancer Res., 52, 1916-1923.
15. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA and Ullrich A. (1990). Cancer Res., 50, 1550-1558.
16. Flick DA and Gifford GE. (1984). J. Immunol. Methods, 68, 167-175.
17. Gillies RJ, Didier N and Denton M. (1986). Analytical Biochem., 159, 109-113.
18. Giovanella BC, Stehoin JS and Shepard RC. (1977). Proceedings of the Second International Workshop on Nude Mice. Nomura T, Ohsawa N, Tamaoki N and Fujiwara K, (eds.), Univ. of Tokyo Press. pp. 475-481.
19. Hanauske AR, Osborne CK, Chamness GC, Clark GM, Forseth BJ, Buchok JB, Arteaga CL and Von Hoff DD. (1987). Euro. J. Cancer Clin., 23, 545-551.
20. Hancock MC, Langton BC, Chan T, Toy P, Monahan JJ, Mischak RP and Shawver LK. (1991). Cancer Res., 51, 4575-4580.
21. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS and Podratz KC. (1992). Gynecol. Oncol., 47, 179-185.
22. Hill AV. (1913). Biochem. J., 7, 471-480.
23. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard HM, Kuang W-J, Wood WI, Goeddel DV and Vandlen RL. (1992). Science, 256, 1205-1210.
24. Hudziak RM, Lewis GD, Winget M, Fendly BM, Shepard HM and Ullrich A. (1989). Molec. & Cell. Biol., 9, 1165-1172.
25. Hsu S, Pegram MD, Pietras RJ, Beryt M and Dennis Slamon. (1997). Basic Clinical Aspects Breast Cancer (abstr.), Keystone, CO.
26. Inaba M, Kobayashi T, Tashiro T and Sakurai Y. (1988). Jpn. J. Cancer Res. (Gann). 79, 509.
27. Klapper LN, Vaisman N, Hurwitz E, Pinkas-Kramarski R, Yarden Y and Sela M. (1997). Oncogene, 14, 2099-2109.
28. Lukes AS, Kohler MF, Pieper CF, Kerns BJ, Bentley R, Rodriguez GC, Soper JT, Clarke-Pearson DL, Bast Jr RC and Berchuck A. (1994). Cancer, 73, 2380-2385.
29. Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y and Bast Jr RC. (1991). Cancer Res., 51, 5361-5369.
30. Park JW, Stagg R, Lewis GD, Carter P, Maneval D, Slamon DJ, Jaffe H and Shepard HM. (1992). Cancer Treatment Res., 61, 193-211.
31. Pegram MD, Pietras RJ and Slamon DJ. (1992). Proc. Am. Assoc. Cancer Res., 33, 442.
32. Pegram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ and Slamon DJ. (1997). Oncogene, 15, 537 547.
33. Pegram MD, Lipton A, Hayes D, Weber B, Baselga JM, Tripathy D, Baly D, Baughman SA, Twaddell T, Glaspy J and Slamon DJ. (1998). J. Clin. Oncol., 16, 2659-2671.
34. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB and Slamon DJ. (1994). Oncogene, 9, 1829-1838.
35. Press MF , Pike MC, Hung G, Zhou JY, Ma Y, George J, Dietz-Band J, James W, Slamon DJ, Batsakis JG and El-Naggas AK. (1994). Cancer Res., 54, 5675-5682.
36. Reese DM, Arboleda J, Twaddell J, Akita R, Sliwkowski MX and Slamon DJ. (1996). Proc. Am. Assoc. Cancer Res., 37, 51 (abstr 353).
37. Reile H, Birnbock H, Bernhardt G, Spruss T and Schonenberger H. (1990). Analytical Biochem., 187, 262-267.
38. Rodriguez GC, Boente MP, Berchuck A, Whitaker RS, O'Briant KC, Xu F and Bast Jr, RC. (1993). Am. J. Obstet. and Gynecol., 168, 228-232.
39. Saffari B, Jones LA, el-Naggar A, Felix JC, George J and Press MF. (1995). Cancer Res., 55, 5693-5698.
40. Semba K, Kamata N, Toyoshima K and Yamamoto T. (1985). Proc. Natl. Acad. Sci. USA, 82, 6497-6501.
41. Sias PE, Kotts CE, Vetterlein D, Shepard M and Wong WL. (1990). J. Immunol. Methods, 132, 73-80.
42. Slamon DJ, Clark GM, Wong SJ, Levin WJ, Ullrich A and McGuire WL. (1987). Science, 235, 177-182.
43. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A and Press MF. (1989). Science, 244, 707-712.
44. Tannock IF. (1978). Cancer Treat Rep., 62, 1117-1133.
45. Yarden Y. (1990). Proc. Natl. Acad. Sci. USA, 87, 2569-2573.
46. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M and Sasaki T. (1991). Cancer, 67, 2914-2918.
47. Zuckier G and Tritton TR. (1983). Exper. Cell Res., 148, 155-161.